Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries
- PMID: 36958305
- PMCID: PMC10413786
- DOI: 10.1159/000530275
Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries
Conflict of interest statement
J.M. received speaker’s fees/honoraria and conference sponsorship from Lilly, Roche, and Viatris. M.T., R.P., P.M., D.D., C.D., S.B., and E.A. have no conflicts of interest to declare. A.O. is a speaker at AstraZeneca, Roche, J and J and Otsuka and principal investigator for various phase III clinical trials involving AstraZeneca, Roche, and Nanoray. M.B. is a consultant to Viatris and received financial support from Viatris. S.D. received honoraria from Novartis, Pfizer, Lilly, AstraZeneca, Roche, MSD, BMS, New Bridge, and Caris and received research funding from MSD, Amgen, and the Al Jalila Foundation.
References
Publication types
LinkOut - more resources
Full Text Sources